In The News Posted February 27, 2019 Share Posted February 27, 2019 SALT LAKE CITY, Feb. 27, 2019 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that new data from five abstracts on the company's pipeline of investigational agents... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.